Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA -0.4EWJ 0.37TECK.B.TO -2.09CNQ.TO 0.71HHL.TO 0.075SYLD 0.03HAC.TO 0.04TRU -0.01
Amgen Inc. (AMGN)

NASDAQ:AMGN

Amgen Inc. (AMGN)

336.13
-1.47 (0.44%)
as of Jun 18, 2026, 10:19:00 pm Market Open.
47 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
SELL

Amgen Inc.(AMGN)

Aug 04, 2005
Model price has been the same at $53.30. The increase in the stock price has been a little overdone.
Photo of Brian Acker, CABrian Acker, CA
No
Unlock Rating
$82.68

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
Track your Stocks in your Watch List
BUY

Amgen Inc.(AMGN)

Mar 17, 2005
Likes the stock. The sector has been weak over the last few months. Has a pretty full pipeline of stuff that could surprise us. Trades at a reasonable multple.
Photo of Ray SteeleRay Steele
Owned
Unlock Rating
$58.95

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Amgen Inc.(AMGN)

Mar 11, 2005
Majority of money is from 3 products. Want's more diversificaion. Good balance sheet though.
Photo of Kevin Vandermeer, B.Comm, CFAKevin Vandermeer, B.Comm, CFA
No
Unlock Rating
$59.81

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Amgen Inc.(AMGN)

Aug 13, 2004
Likes the health-care sector. One of the top companies. Has underperformed for a long time, but they are willing to be patient.
Photo of Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$54.36

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Amgen Inc.(AMGN)

Aug 13, 2004
A very rapidly growing company. Earnings per share growth is in excess of 20% yearly. PE ratio barely more than that.
Photo of Samuel D. IsalySamuel D. Isaly
Owned
Unlock Rating
$54.36

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Amgen Inc.(AMGN)

Jul 16, 2004
Under a cloud. Driven down because of generic drugs and imports from Canada. Medicare will be onerous. Powerful balance sheet.
Photo of Alan BlakeAlan Blake
Owned
Unlock Rating
$55.73

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Amgen Inc.(AMGN)

May 14, 2004
Health care should outperform in a rising interest rate environment. A premier company. Likes the pipeline that it has. Out-of-favor right now.
Photo of Nicholas SargenNicholas Sargen
Owned
Unlock Rating
$56.65

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Amgen Inc.(AMGN)

May 11, 2004
(A top pick in Feb/04. Down a bit.) This sector has great prospects on a going forward basis but will be volatile on a short-term basis. A leader in their field. Good growth prospects.
Photo of John Sinkins, CFAJohn Sinkins, CFA
Owned
Unlock Rating
$57.14

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
Track your Stocks in your Watch List
TOP PICK

Amgen Inc.(AMGN)

Apr 02, 2004
Photo of Nicholas SargenNicholas SargenUnlock Rating
$59.51

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Amgen Inc.(AMGN)

Mar 09, 2004
A leading biotech company. Trading at 22 X next year's earnings. Pretty cheap for this quality of a company.
Photo of John Sinkins, CFAJohn Sinkins, CFA
Owned
Unlock Rating
$62.76

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
BUY

Amgen Inc.(AMGN)

Dec 29, 2003
A very mature biotech company. Expects about 10/15% revenue growth and about 20/25% earnings growth. Trading at a low multiple.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$61.87

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Amgen Inc.(AMGN)

Nov 03, 2003
(A top pick July 15/03. Down 13.7%.) Sold the stock in the summer.
Photo of David BurrowsDavid Burrows
No
Unlock Rating
$61.15

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Amgen Inc.(AMGN)

Nov 03, 2003
Has made some good acquisitions in the last couple of years, which has propped up their product line. 25 X next year's earnings.
Photo of John Sinkins, CFAJohn Sinkins, CFA
Owned
Unlock Rating
$61.19

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
BUY

Amgen Inc.(AMGN)

Oct 22, 2003
They don't have the problem of drugs going off patent. The stock can go much higher. Dropping currently because the sector is pulling it down.
Photo of Paul O'NeilPaul O'Neil
No
Unlock Rating
$60.30

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Amgen Inc.(AMGN)

Jul 22, 2003
Was a top pick on Jun 4/03. Up 7%.) The leader in bio techs. Has grown its earnings every year since 1994.
Photo of David BurrowsDavid BurrowsUnlock Rating
$68.93

Stock price when the opinion was issued

$336.13

As of Jun 18, 2026. Market Open.

biotechnologypharmaceutical
Showing 91 to 105 of 124 entries

You may also like

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV 0$153.3
WSP.TO 1.13$176.7
VRTX 0.47$452.1
OTEX.TO 0.24$29.47
CCO.TO 0.61$151.07

Today's Top Picks

NVDA -0.4$210.29
EWJ 0.37$96.63
TECK.B.T… -2.09$88.93
CNQ.TO 0.71$58.66
HHL.TO 0.075$6.865

Popular Articles

Latest Sell Signals

TD.TO 0.7$169.33
MBLY -0.03$8.43
ASAN 0.03$6.95
MODG -0.01$18.21
NVTS 0$24.02

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica